Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(S)-N-(1-((R)-1-amino-1-oxo-3-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)propan-2-ylamino)-2-methyl-1-oxopropan-2-yl)-1-((3S,6S,9S,12S,15S,18S)-18-amino-6-(2-amino-2-oxoethyl)-9-(3-amino-3-oxopropyl)-12-sec-butyl-15-(4-hydroxybenzyl)-5,8,11,14,17,20-hexaoxo-1,4,7,10,13,16-hexaazacycloicosane-3-carbonyl)pyrrolidine-2-carboxamide
ID: ALA5280014
Max Phase: Preclinical
Molecular Formula: C49H75N13O19
Molecular Weight: 1150.21
Associated Items: